1. NOVTNovanta Inc. · Nasdaq
Priority diligence · Direct product fitWhat it makes: Frameless motors, encoders, servo drives and force/torque sensors for robot joints. Sells parts for humanoid joints on its own site. First in line for diligence: the commercial steps are still unproven.
- Undated pageConfirmedRecommends Omni+ Series frameless motors, IncOder CORE inductive angle encoders, Everest Safe servo drives and Varo force/torque sensors for humanoids. Novanta
- Undated pageConfirmedSays its frameless motors and miniature encoders free space in knees, elbows and wrists, and its multi-axis force/torque sensors support compliant grasping, collision detection and adaptive manipulation. Novanta
- Undated pageConfirmedJoined the NVIDIA Halos AI Systems Inspection Lab to align its hardware with NVIDIA platforms for warehouse automation, industrial robotics and emerging humanoid platforms. A collaboration, not a purchase order or a named humanoid award. Novanta
- May 11, 2026Target / outlookQ1 2026 release (three months ended April 3, 2026), CEO: "building momentum" in AI-driven advanced industrial and semiconductor markets, advanced robotics, and minimally invasive and robotic surgery. Advanced robotics is one market among several, not humanoids alone. Novanta, May 11, 2026 (SEC copy)
- Aug 5, 2026Company-wideQ2 2026 (three months ended July 3, 2026): GAAP revenue of $265.8 million, up 10.3% on the prior year. Novanta, Aug 5, 2026 (SEC copy)
- Aug 5, 2026Company-wideAfter closing the Riverpoint Medical acquisition, management puts medical end-market exposure at approximately 60% of revenue and recurring medical consumables at approximately 25% of sales on an annualized basis. Novanta, Aug 5, 2026 (SEC copy)
- Named humanoid robot makers as customers, or design wins
- Production orders, as opposed to prototypes
- Content per robot and repeat orders
- Humanoid revenue apart from surgery, semiconductor and other industrial sales
- A disclosed humanoid design win with its program stage
- Production orders rather than prototype orders
- Content per robot and repeat-order conversion
- Humanoid revenue reported apart from surgery, semiconductor and other industrial sales
No 10-K, 10-Q or 8-K filed after Oct 22, 2026.
Latest quarterly or annual report: 10-Q filed Aug 5, 2026. All filings on EDGAR
